Combined with the results of pharmacodynamics, we found that RS-FZ significantly ameliorated myocardial fibrosis, enhanced cardiac function, and reduced the serum HF marker (BNP) level in rats with HF, with an apparent therapeutic effect. The gene discussed is NPPB; the disease is hydrops fetalis.